Aligos Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aligos Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.9k | 708 | 9.80 |
| 2025-03-31 | $214 | 26 | 8.27 |
| 2024-12-31 | $1.0k | 26 | 39.85 |
| 2024-09-30 | $224 | 26 | 8.65 |